Accuracy of time to treatment estimates in the CRASH-3 clinical trial: impact on the trial results. (2020)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-020-04623-5
PubMed Identifier: 32711551
Publication URI: http://europepmc.org/abstract/MED/32711551
Type: Journal Article/Review
Volume: 21
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215